|
Characteristic
|
Patients (n = 27)
|
(%)
|
|---|
|
Male
|
23
|
85.2
|
|
Female
|
4
|
14.8
|
|
Age (y)
|
|
Range
|
50-90
| |
|
Median
|
70
| |
|
T stage
|
|
T3
|
25
|
92.6
|
|
T4
|
2
|
7.4
|
|
N stage
|
|
N0
|
0
|
0
|
|
N1
|
16
|
59.3
|
|
N2
|
10
|
37.0
|
|
N3
|
1
|
3.7
|
|
Stage
|
|
IIIA
|
15
|
55.6
|
|
IIIB
|
9
|
33.3
|
|
IIIC
|
3
|
11.1
|
|
Location of the lesion
|
|
Ut
|
5
|
18.5
|
|
Mt
|
9
|
33.3
|
|
Mt./Lt
|
6
|
22.2
|
|
Lt
|
5
|
18.5
|
|
Lt/Ae
|
2
|
7.4
|
|
Chemotherapy
|
|
5-Fu + CDDP
|
16
|
59.3
|
|
5-Fu + nedaplatin
|
7
|
25.9
|
|
5-Fu
|
1
|
3.7
|
|
Radiotherapy alone
|
3
|
11.1
|
- Abbreviations: Ut upper thoracic esophagus, Mt. middle thoracic esophagus, Lt lower thoracic esophagus, Ae abdominal esophagus, Fu fluorouracil, CDDP cisplatin
